Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
Does TNF have anti-osteoclastogenic actions?
Jameel Iqbal
Icahn School of Medicine at Mount Sinai
Medicine
Medicine - Endocrinology, Diabetes and Bone Disease
Research output
:
Contribution to journal
›
Article
›
peer-review
2
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Does TNF have anti-osteoclastogenic actions?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Tumor Necrosis Factor-α
100%
Osteoclast Differentiation
23%
Osteopenia
15%
Osteoprotegerin
15%
Osteoclast Formation
15%
Macrophages
7%
Overexpression
7%
Mechanism of Action
7%
Induced Expression
7%
Synergize
7%
Granulocyte Colony-stimulating Factor (G-CSF)
7%
Stromal Cells
7%
Resorption
7%
Osteoclast
7%
Cathepsin K
7%
Osteoblast Differentiation
7%
Osteoclast Precursors
7%
Marker Expression
7%
Bone Degradation
7%
Biochemistry, Genetics and Molecular Biology
Tumor Necrosis Factor
100%
Osteoclastogenesis
38%
RANKL
30%
Osteoprotegerin
15%
Osteoclast
15%
Precursor
7%
Macrophage
7%
Stromal Cell
7%
Osteoblast
7%
Macrophage Colony-Stimulating Factor
7%
Cathepsin K
7%
RANK
7%
Immunology and Microbiology
Tumor Necrosis Factor
100%
Osteoclastogenesis
38%
RANKL
30%
Osteoclast
15%
Osteoprotegerin
15%
Macrophage
7%
Precursor
7%
Osteoblast
7%
Macrophage Colony-Stimulating Factor
7%
RANK
7%
Neuroscience
Necrosis
100%
Osteoclast
53%
RANKL
30%
Osteoprotegerin
15%
Macrophage
7%
Macrophage Colony-Stimulating Factor
7%
RANK
7%
Cathepsin K
7%
Pharmacology, Toxicology and Pharmaceutical Science
Tumor Necrosis Factor
100%
Osteoclast Differentiation Factor
30%
Osteoprotegerin
15%
Osteopenia
15%
Colony Stimulating Factor 1
7%
Bone Defect
7%
Cathepsin K
7%